<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Top Legal News &#187; Federal Circuit</title>
	<atom:link href="http://www.top-legal-news.com/category/federal-circuit/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.top-legal-news.com</link>
	<description>Daily Legal News and Updates</description>
	<lastBuildDate>Sat, 31 Jul 2010 20:20:33 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-10/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-10/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-10/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/4cdd5_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/2f825_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/a4f50_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/bcb6e_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-10/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-11/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-11/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-11/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/4cdd5_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/3f617_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/a4f50_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/bcb6e_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/bcb6e_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-11/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-8/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-8/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-8/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/3f617_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-8/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-9/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-9/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-9/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/3f617_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/2f825_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-9/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-6/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-6/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-6/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/f43c6_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/4cdd5_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/3f617_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-7/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-7/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-7/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/f43c6_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/3f617_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-7/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-4/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-4/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-4/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ad1dd_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/f43c6_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/4cdd5_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-4/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-5/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-5/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-5/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/f43c6_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/4cdd5_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ec95f_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-5/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-2/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-2/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ad1dd_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/f43c6_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent for Cancer Drug Invalid for Obviousnessp-Type Double Patenting</title>
		<link>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-3/</link>
		<comments>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-3/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 23:59:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Federal Circuit]]></category>

		<guid isPermaLink="false">http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-3/</guid>
		<description><![CDATA[Sun Pharm. Indus. Ltd. v. Eli Lilly &#38; Co., 10-1105, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co., 10-1105</a>, concerned a challenge to the district court&#8217;s judgment finding certain claims of the patent invalid for obviousness-type double patenting over another patent, in a generic drug manufacturer&#8217;s suit for a declaratory judgment against Eli Lilly, seeking declaratory relief that a patent related to treating various forms of cancer is invalid and not infringed.&nbsp; In affirming, the court held that the district court correctly followed the double patenting analysis of the Geneva line of cases, which address the situation in which an earlier patent claims a compound, disclosing the utility of that compound in the specification, and a later patent claims a method of using that compound for a particular use described in the specification of the earlier patent.</p>
<p><u><strong>Related Resource:</strong></u></p>
<ul>
<li>Full text of <a href="http://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2010/07/28/250909.html">Sun Pharm. Indus. Ltd. v. Eli Lilly &amp; Co</a></li>
</ul>
<div>
<a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:yIl2AUoC8zA"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/ad1dd_FindLawFed?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/f43c6_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/45049_FindLawFed?i=vj1aY8QrDoI:EsznB1YS24s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.findlaw.com/~ff/FindLawFed?a=vj1aY8QrDoI:EsznB1YS24s:l6gmwiTKsz0"><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/e2dfa_FindLawFed?d=l6gmwiTKsz0" border="0"></img></a>
</div>
<p><img src="http://www.top-legal-news.com/wp-content/plugins/wp-o-matic/images/4cdd5_vj1aY8QrDoI" height="1" width="1" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.top-legal-news.com/patent-for-cancer-drug-invalid-for-obviousnessp-type-double-patenting-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
